- Home
- SPPP vs MYO Comparison
SPPP vs MYO Comparison
Compare SPPP & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- MYO
- Stock Information
- Founded
- SPPP 2011
- MYO 2004
- Country
- SPPP Canada
- MYO United States
- Employees
- SPPP N/A
- MYO N/A
- Industry
- SPPP
- MYO Industrial Specialties
- Sector
- SPPP
- MYO Health Care
- Exchange
- SPPP NYSE
- MYO Nasdaq
- Market Cap
- SPPP 139.1M
- MYO 157.9M
- IPO Year
- SPPP N/A
- MYO 2017
- Fundamental
- Price
- SPPP $9.15
- MYO $6.26
- Analyst Decision
- SPPP
- MYO Strong Buy
- Analyst Count
- SPPP 0
- MYO 4
- Target Price
- SPPP N/A
- MYO $8.25
- AVG Volume (30 Days)
- SPPP 263.6K
- MYO 361.0K
- Earning Date
- SPPP 01-01-0001
- MYO 11-06-2024
- Dividend Yield
- SPPP N/A
- MYO N/A
- EPS Growth
- SPPP N/A
- MYO N/A
- EPS
- SPPP N/A
- MYO N/A
- Revenue
- SPPP N/A
- MYO $25,239,125.00
- Revenue This Year
- SPPP N/A
- MYO $53.19
- Revenue Next Year
- SPPP N/A
- MYO $39.01
- P/E Ratio
- SPPP N/A
- MYO N/A
- Revenue Growth
- SPPP N/A
- MYO 36.23
- 52 Week Low
- SPPP $8.55
- MYO $2.51
- 52 Week High
- SPPP $11.39
- MYO $6.75
- Technical
- Relative Strength Index (RSI)
- SPPP 40.95
- MYO 64.23
- Support Level
- SPPP $9.22
- MYO $5.84
- Resistance Level
- SPPP $9.37
- MYO $6.50
- Average True Range (ATR)
- SPPP 0.12
- MYO 0.42
- MACD
- SPPP 0.02
- MYO -0.03
- Stochastic Oscillator
- SPPP 36.92
- MYO 70.36
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).